12 news items
Nurix Therapeutics Announces Board Chair Transition
NRIX
20 May 24
has been instrumental in our growth from a private, ligase research company to a public, drug discovery and development company with three innovative
Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference
NRIX
7 May 24
is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative small molecules and antibody
Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
NRIX
16 Apr 24
of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
NRIX
11 Apr 24
of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer
Nurix Therapeutics Announces Proposed Public Offering
NRIX
11 Apr 24
biopharmaceutical company focused on the discovery, development and commercialization of innovative small molecules and antibody therapies based
b3vb1y8xtz0dxhmsegypk64omj3w30028c0jw ypyy9evgnshw5d1qec
NRIX
9 Apr 24
, development and commercialization of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel
1bromtnan80o8mfx6sdolbpeeb4ssq6ndd5nqof2lon18w
NRIX
2 Apr 24
focused on the discovery, development and commercialization of innovative small molecules and antibody therapies based on the modulation of cellular protein
dgetu7l535
NRIX
25 Mar 24
Research UK, whose goal is to facilitate identification of the greatest challenges in cancer today and to fund global teams to work in innovative ways
kkk6vgj58nacris a8c32yh0clepl
NRIX
20 Mar 24
Presentation highlights Nurix's innovation and leadership in targeted protein modulation, including ligase inhibition
oww8ozba
NRIX
20 Mar 24
Nurix's innovation and leadership in targeted protein modulation, including ligase inhibition Unique
3p8yhfhw4jfh6911oi1u4bza1knw6ed9oo26 hoiuegjguvvo6sdf83wra
NRIX
11 Mar 24
of innovative small molecules and antibody therapies based on the modulation of cellular protein levels as a novel treatment approach for cancer
ldjpcxxveemlne70l19fa6qrddoy8zx38
NRIX
6 Mar 24
Nurix Therapeutics is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative
- Prev
- 1
- Next